Cargando…
Potential of regulatory T-cell-based therapies in the management of severe COVID-19
In view of dysregulated immune response, “cytokine storm” and inflammation-induced lung damage in severely ill COVID-19 patients, we propose that CD4(+)CD25(+)FoxP3(+) regulatory T-cell-based therapies could be considered for patient management https://bit.ly/3eKqWPo
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331657/ https://www.ncbi.nlm.nih.gov/pubmed/32616599 http://dx.doi.org/10.1183/13993003.02182-2020 |